Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | 38.97 Million USD | 661.86% |
| 2021 | -5.28 Million USD | -108.76% |
| 2020 | 60.35 Million USD | 66.43% |
| 2019 | 36.26 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 6.58 Million USD | -83.79% |
| 2023 Q3 | 11.37 Million USD | -65.96% |
| 2023 Q2 | 33.39 Million USD | 407.57% |
| 2022 FY | 29.71 Million USD | 661.86% |
| 2022 Q4 | 40.59 Million USD | 134.01% |
| 2022 Q3 | 17.34 Million USD | 82.63% |
| 2022 Q2 | 9.49 Million USD | 326.68% |
| 2022 Q1 | 2.22 Million USD | 106.78% |
| 2021 Q1 | -1.1 Million USD | -103.37% |
| 2021 FY | -5.28 Million USD | -108.76% |
| 2021 Q2 | 14.62 Million USD | 1419.03% |
| 2021 Q4 | -32.85 Million USD | -289.97% |
| 2021 Q3 | 17.29 Million USD | 18.22% |
| 2020 Q4 | 32.9 Million USD | 162.94% |
| 2020 Q3 | 12.51 Million USD | -24.05% |
| 2020 Q1 | -8.42 Million USD | 0.0% |
| 2020 FY | 60.35 Million USD | 66.43% |
| 2020 Q2 | 16.47 Million USD | 295.64% |
| 2019 FY | 36.26 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Journey Medical Corporation | -2.07 Million USD | 1980.029% |
| Safety Shot Inc | -12.18 Million USD | 419.866% |
| Bright Green Corporation | -8.89 Million USD | 538.323% |
| Alvotech | -354.86 Million USD | 110.983% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 358.065% |
| Cosmos Health Inc. | -21.83 Million USD | 278.52% |
| Dynavax Technologies Corporation | -37.02 Million USD | 205.253% |
| Embecta Corp. | 221.5 Million USD | 82.405% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 125.053% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 124.453% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 55.548% |
| PainReform Ltd. | -9.58 Million USD | 506.646% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 914.432% |
| SCYNEXIS, Inc. | 72.66 Million USD | 46.369% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | 1649.489% |
| Alpha Teknova, Inc. | -35.56 Million USD | 209.589% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 17.028% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 76.657% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 914.432% |
| Theratechnologies Inc. | -10.62 Million USD | 466.736% |
| Harrow Health, Inc. | 580 Thousand USD | -6619.483% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | 929.036% |
| Biofrontera Inc. | -22.67 Million USD | 271.861% |
| DURECT Corporation | -36.88 Million USD | 205.664% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | 839.666% |
| Cronos Group Inc. | -81.37 Million USD | 147.893% |
| OptiNose, Inc. | -22.74 Million USD | 271.325% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 81.356% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 199.54% |
| RedHill Biopharma Ltd. | 12.63 Million USD | -208.526% |
| Organogenesis Holdings Inc. | 12.52 Million USD | -211.162% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | 998.758% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 727.502% |
| Radius Health, Inc. | -3.92 Million USD | 1092.943% |
| Universe Pharmaceuticals INC | -3.52 Million USD | 1205.061% |
| ProPhase Labs, Inc. | -21.61 Million USD | 280.322% |
| Phibro Animal Health Corporation | 53.31 Million USD | 26.9% |
| Procaps Group S.A. | 52.32 Million USD | 25.516% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 557.269% |
| Viatris Inc. | 766.2 Million USD | 94.913% |
| Rockwell Medical, Inc. | -6.67 Million USD | 684.303% |
| Aytu BioPharma, Inc. | -5.25 Million USD | 841.778% |
| SIGA Technologies, Inc. | 83.62 Million USD | 53.393% |
| Tilray Brands, Inc. | -174.74 Million USD | 122.303% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | -317.672% |
| Shineco, Inc. | -17.06 Million USD | 328.368% |
| PetIQ, Inc. | 60.01 Million USD | 35.061% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | 922.784% |
| Incannex Healthcare Limited | -30.04 Million USD | 229.733% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 84.467% |
| Alimera Sciences, Inc. | -1.47 Million USD | 2749.422% |
| Silver Spike Investment Corp. | 7.34 Million USD | -430.959% |
| Assertio Holdings, Inc. | -243.53 Million USD | 116.003% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | 761.414% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 386.201% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 349.923% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 294.378% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 128.272% |
| Hempacco Co., Inc. | -8.81 Million USD | 542.258% |
| Talphera, Inc. | -16.88 Million USD | 330.76% |
| Alvotech | -354.86 Million USD | 110.983% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 27.091% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 89.312% |
| Currenc Group, Inc. | -6.64 Million USD | 686.432% |
| Kamada Ltd. | 10.06 Million USD | -287.252% |
| Indivior PLC | -4 Million USD | 1074.325% |
| Evoke Pharma, Inc. | -7.43 Million USD | 624.473% |
| Flora Growth Corp. | -50.35 Million USD | 177.398% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 294.378% |
| Evolus, Inc. | -49.23 Million USD | 179.16% |
| HUTCHMED (China) Limited | 18.37 Million USD | -112.098% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 80.215% |
| Akanda Corp. | -10.05 Million USD | 487.738% |